期刊文献+

VEGF-C短发夹RNA对人乳腺癌细胞的体内外抑制作用的实验研究 被引量:1

Short hairpin RNA-mediated inhibition of VEGF-C on human breast cancer cells in vitro and in vivo
下载PDF
导出
摘要 目的:探讨靶向血管内皮生长因子-C(VEGF-C)的短发夹RNA(shRNA)质粒载体在体内外对乳腺癌细胞株MCF-7生物学活性的抑制作用。方法:倒置荧光显微镜及流式细胞术检测细胞的转染率,RT-PCR及免疫印迹法检测转染细胞内VEGF-C mRNA及蛋白的表达变化,MTT法检测细胞增殖抑制率,人工基底膜侵袭实验检测细胞侵袭能力。MCF-7裸鼠皮下尾静脉注射VEGF-C shRNA表达载体,观察其对乳腺癌生长的抑制作用。ELISA方法检测VEGF-C在肿瘤组织中的蛋白浓度,免疫组织化学分析肿瘤组织VEGFR-3阳性脉管密度。结果:VEGF-C shRNA能高效转染入MCF-7细胞中,细胞VEGF-C mRNA及蛋白表达水平显著下降,生长增殖受抑(F24 h=515.51,F48 h=859.97,F72 h=992.91,P均=0.000 1)。体外侵袭人工基底膜能力减弱(F=133.36,P=0.000 1)。全身系统性给予VEGF-C shRNA后,VEGF-C shRNA组肿瘤体积缩小(F=498.05,P=0.000 1);瘤组织VEGF-C浓度降低(t=30.75,P=0.001);免疫组化分析VEGF-C shRNA组肿瘤组织中VEGFR-3阳性脉管生成减少(F=265.49,P=0.000 1)。结论:VEGF-C在乳腺癌增殖、侵袭转移和VEGFR-3阳性脉管形成中发挥重要作用,通过RNA干扰技术实现VEGF-C沉默在乳腺癌的基因治疗中具有较好的应用前景。 OBJECTIVE: To investigate the anti-tumor effect of shot hairpin RNA(shRNA)-mediated inhibition of VEGF-C on human breast cancer in vitro and in vivo.METHODS:Transfection rate was observed by inverted fluorescence microscope and flow cytometry.The expression of VEGF-C was determined in transfected cells by RT-PCR and Western blot.The cell-growth inhibition rate and the invasive capacity were evaluated by the MTT method and reconstituted basement membrane invasion assay.VEGF-C shRNA vector was injected from the tail vain of the tumor model mice after tumor cell innoculation.The concentration of VEGF-C in tumor homogenates was detected by ELISA.VEGFR-3 positive vessels in tumor tissues were measured by immunohistochemical analyses.RESULTS: VEGF-C shRNA specifically and effectively downregulated VEGF-C mRNA and protein expression in vitro,and it also effectively inhibited proliferation(F24 h=515.51,F48 h=859.97,F72 h=992.91,P=0.000 1) and invasive capacity(F=133.36,P=0.000 1) of MCF-7 cells.The treatment with VEGF-C shRNA in vivo suppressed tumor growth significantly,F=498.05,P=0.000 1;VEGF-C ELISA of tumor homogenates confirmed RNA interference(t=30.75,P=0.001);immunohistochemical analyses demonstrated significant reduction of VEGFR-3 positive vascular formation in tumor tissues(F=265.49,P=0.000 1).CONCLUSIONS: VEGF-C plays an important role in tumor growth,invasive capacity and lymphangiogenesis of breast cancer.RNA interfering target VEGF-C may serve as potential therapeutic interventions in human breast cancer.
出处 《中华肿瘤防治杂志》 CAS 2008年第18期1377-1380,1385,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 广东省社会发展领域科技计划项目(2006B35530001)
关键词 血管内皮生长因子C/遗传学 乳腺肿瘤 RNA干扰 vascular endothelial growth factor C/genetics breast neoplasms RNA interference
  • 相关文献

参考文献6

  • 1Veeravagu A, Hsu A R, Cai W, et al. Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy[J]. Recent patents Anticancer Drug Discov, 2007,2(1):59-71.
  • 2肖芸,李金高.血管内皮生长因子C的研究进展[J].中华肿瘤防治杂志,2007,14(8):631-634. 被引量:12
  • 3Plate K. From angiogenesis to lymphangiogenesis[J]. Nat Med, 2001,7(2) :151-152.
  • 4曲明阳,邢光明,赵莉,冯秉安.乳腺癌组织中eIF-4E基因对VEGF-C表达及淋巴转移的影响[J].中华肿瘤防治杂志,2007,14(9):686-688. 被引量:3
  • 5Tumoshenko A V, Rastogi S, Lala P K. Migration-promoting role of VEGF-C and binding receptors in human breast cancer cells[J]. Br J cancer,2007,97(8) : 1090-1098.
  • 6Kuhn H, Hammerschmidt S, Wirtz H. Targeting tumorangio genesis in lung eaeer by suppression of VEGF and its receptor-re sults from clinical trials and novel ecperimental approaches[J]. Curr Med Chem, 2007,14(30) :3157-3165.

二级参考文献11

  • 1Department of Hepatobiliary Surgery (Tang RF, Zhang FR, Peng L, Wang SX, Xiao Y and Zhang M),and Department of Dermatology (Wang SX), 4th Hospital, Hebei Medical University, Shijiazhuang 050011, China.Interleukin-1α, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer[J].Hepatobiliary & Pancreatic Diseases International,2005,4(3):460-463. 被引量:6
  • 2马凤江,智绪亭.血管内皮生长因子-C在胃癌组织中的表达及与肿瘤淋巴结转移的关系[J].肿瘤防治杂志,2005,12(4):281-282. 被引量:12
  • 3罗景玉,杨长征,李道堂,张百江.非小细胞肺癌组织中VEGFR-3的表达及临床意义[J].中华肿瘤防治杂志,2006,13(15):1178-1179. 被引量:19
  • 4Schoppmann S F,Fenzl A,Nagy K,et al.VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer:impact on lymphangiogenesis and survival[J].Surgery,2006,139(6):839-846.
  • 5Li Y S,Kaneko M,Amatya V J,et al.Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast[J].Pathol Int,2006,56(5):256-261.
  • 6de Benedetti A,Graff J R.eIF-4E expression and its role in malignancies and metastases[J].Oncogene,2004,23(18):3189-3199.
  • 7Byrnes K,White S,Chu Q,et al.High eIF4E,VEGF,and microvessel density in stage Ⅰ to Ⅲ breast cancer[J].Ann Surg,2006,243(5):684-690.
  • 8Fromowitz F B,Viola M V,Chao S,et al.Ras p21 expression in the progression of breast cancer[J].Human Pathol,1987,18:1268-1275.
  • 9Weidner N,Folkman J,Pozza F,et al.Tumor angiogenesis:a new significant and independent prognostic indicator in early-stage breast carcinoma[J].J Natl Cancer Inst,1992,84(24):1875-1887.
  • 10De Benedetti A,Harris A L.eIF4E expression in tumors:its possible role in progression of malignancies[J].Int J Biochem Cell Biol,1999,31(1):59-72.

共引文献12

同被引文献2

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部